81305 Myd88 gene p.leu265pro vrnt
Pathology & Lab
Also known as: MYD88 L265P testing, lymphoplasmacytic lymphoma genetic test
Myeloid Differentiation Primary Response gene (MYD88) gene analysis for the pathogenic p.Leu265Pro variant associated with lymphoplasmacytic lymphoma.
Clinical Context
Detects MYD88 L265P variant present in majority of lymphoplasmacytic lymphomas and Waldenstrom macroglobulinemia cases.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.